TransMedics: 2027 Setting Up To Be A Pivotal Year

TransMedics' stock was upgraded by an analyst, who expects 2027 to be a pivotal year for the company. The analyst cited the company's strong pipeline and potential for growth in the organ transplant market.

The analyst also expressed optimism about the company's recent partnership with a major hospital network.